Nervonik Announces $52.5M Series B Financing
Summary
LOS ANGELES, CA, Nervonik, Inc., a clinical-stage medical device company, announced the closing of a $52.5 million Series B financing led by Amzak Health.
Description
LOS ANGELES, CA, Nervonik, Inc., a clinical-stage medical device company, announced the closing of a $52.5 million Series B financing led by Amzak Health.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source